Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIG MS
2019 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIG MS
Deiva, K.; Huppke, P. ; Banwell, B.; Chitnis, T.; Gärtner, J. ; Krupp, L. & Waubant, E. et al. (2019)
Journal of Neurology, Neurosurgery & Psychiatry, pp. jnnp-2019-321124. DOI: https://doi.org/10.1136/jnnp-2019-321124
